BioTalent
Contract Senior CRA - Oncology (12-Month Contract, UK Remote)
(Outside IR35)
|
UK Remote
|
Phase III Solid Tumor Trial
We are partnering with a fast-growing, innovative biotechnology company advancing cutting-edge immuno-oncology therapies. As they scale their pivotal
Phase III Solid Tumor study , they are seeking an experienced
Contract Clinical Research Associate (CRA)
to join their UK team.
This is a fantastic opportunity to work on a
high-profile, late-phase oncology trial
with a sponsor who values collaboration, innovation, and clinical excellence.
The Role
Contract length:
12 months (with strong potential for extension)
Therapeutic area:
Oncology - Solid Tumors (Phase III)
Coverage:
11 UK sites, supported by a team of 2 CRAs
Location:
Remote (UK-based), with routine travel to sites
Engagement:
Outside IR35 Responsibilities
Conduct routine on-site and remote monitoring (PSV, SIV, IMV, COV) across multiple UK sites.
Ensure full compliance with ICH-GCP, study protocol, and sponsor SOPs.
Maintain strong relationships with investigators and site staff to drive recruitment and data quality.
Oversee SDV/SDR, query resolution, and timely site documentation updates in eTMF.
Support audit/inspection readiness, corrective/preventive actions (CAPAs), and risk-based monitoring activities. Requirements
5+ years CRA experience , with a strong background in oncology trials (solid tumor preferred).
Proven expertise in
Phase II/III oncology studies
within the UK.
Ability to independently manage multiple sites and ensure timely study deliverables.
Strong working knowledge of EDC systems (Medidata Rave preferred), CTMS, and eTMF.
UK-based, with flexibility to travel across assigned sites. Why Apply?
Join a
sponsor-driven study
rather than a CRO environment - your impact will be felt directly on trial outcomes.
Contribute to a
pivotal Phase III oncology program
that has the potential to change treatment landscapes.
Competitive outside IR35 contract rate with long-term engagement potential.
(Outside IR35)
|
UK Remote
|
Phase III Solid Tumor Trial
We are partnering with a fast-growing, innovative biotechnology company advancing cutting-edge immuno-oncology therapies. As they scale their pivotal
Phase III Solid Tumor study , they are seeking an experienced
Contract Clinical Research Associate (CRA)
to join their UK team.
This is a fantastic opportunity to work on a
high-profile, late-phase oncology trial
with a sponsor who values collaboration, innovation, and clinical excellence.
The Role
Contract length:
12 months (with strong potential for extension)
Therapeutic area:
Oncology - Solid Tumors (Phase III)
Coverage:
11 UK sites, supported by a team of 2 CRAs
Location:
Remote (UK-based), with routine travel to sites
Engagement:
Outside IR35 Responsibilities
Conduct routine on-site and remote monitoring (PSV, SIV, IMV, COV) across multiple UK sites.
Ensure full compliance with ICH-GCP, study protocol, and sponsor SOPs.
Maintain strong relationships with investigators and site staff to drive recruitment and data quality.
Oversee SDV/SDR, query resolution, and timely site documentation updates in eTMF.
Support audit/inspection readiness, corrective/preventive actions (CAPAs), and risk-based monitoring activities. Requirements
5+ years CRA experience , with a strong background in oncology trials (solid tumor preferred).
Proven expertise in
Phase II/III oncology studies
within the UK.
Ability to independently manage multiple sites and ensure timely study deliverables.
Strong working knowledge of EDC systems (Medidata Rave preferred), CTMS, and eTMF.
UK-based, with flexibility to travel across assigned sites. Why Apply?
Join a
sponsor-driven study
rather than a CRO environment - your impact will be felt directly on trial outcomes.
Contribute to a
pivotal Phase III oncology program
that has the potential to change treatment landscapes.
Competitive outside IR35 contract rate with long-term engagement potential.